Skip to content
Pakistan Era logo
News

DRAP Warns of Fake Gabica 300mg Batch 533C27 and Sandostatin LAR Batch 380531 in Pakistan

DRAP alerts 58 and 59: Gabica 300mg batch 533C27 is spurious, disowned by Getz Pharma, and Sandostatin LAR batch 380531 was meant for Turkey. What to do now.

Fajr Riaz, author at Pakistan EraFajr Riaz6 min read
یہ صفحہ اردو میں پڑھیں
Plain white capsules and a small clear glass vial on a white tray, for DRAP's rapid alerts on Gabica 300mg and Sandostatin LAR in November 2026

Short answer: DRAP issued two rapid alerts on 17 November 2026. Gabica Capsule 300mg batch 533C27 was found spurious and adulterated, and Getz Pharma says it did not make it. Sandostatin LAR 20mg injection batch 380531 was meant for Turkey and was never supplied to Pakistan through legal channels. Do not use either batch.

The Drug Regulatory Authority of Pakistan (DRAP) posted alert 58, on Gabica, at 11:28 am on Tuesday 17 November, and alert 59, on Sandostatin LAR, at 4:38 pm the same day. Both are rapid alerts, the level DRAP uses for spurious and falsified medicines. Provincial drug inspectors have been told to search the supply chain and seize both batches.

Only the two named batches are covered. Other batches of Gabica and Sandostatin LAR are not named in the alerts.

DRAP rapid alerts of 17 November 2026: alert 58 Gabica 300mg batch 533C27 spurious, alert 59 Sandostatin LAR 20mg batch 380531 not legally supplied

Two batches are named in DRAP's rapid alerts 58 and 59

Alert 58 names one batch of Gabica 300mg capsules and alert 59 names one batch of Sandostatin LAR 20mg injection. The table gives the batch number, the name on the pack and DRAP's finding. If your batch number does not match, the alert does not cover your pack.

MedicineBatchName on the packDRAP findingAlert
Gabica Capsule 300mg (pregabalin)533C27Getz Pharma, KarachiSpurious and adulterated, DTL Punjab, Faisalabad. Getz Pharma has disowned it.58, dated 16 November
Sandostatin LAR 20mg injection (octreotide acetate)380531Novartis Pharmaceutical Manufacturing GmbH, Austria; Nouveaux Pharma, KarachiMeant for the Turkish market, never supplied to Pakistan by Nouveaux Pharma59, dated 17 November

DTL means a provincial Drug Testing Laboratory. The legal meaning of spurious, adulterated and falsified is set out in substandard, adulterated and spurious medicine explained. Every alert DRAP has issued this year is in the full list of DRAP recall alerts for 2026.

Gabica 300mg batch 533C27 is a fake that Getz Pharma disowned

The Drug Testing Laboratory in Faisalabad declared Gabica 300mg batch 533C27 spurious and adulterated under section 3 of the Drugs Act 1976. The pack names Getz Pharma, 29-30/27 Korangi Industrial Area, Karachi, but Getz Pharma has disowned the product.

Each genuine Gabica 300mg capsule contains pregabalin 300mg. Doctors prescribe pregabalin for nerve pain, such as pain from diabetes or shingles, and for some kinds of fits and anxiety. It is a medicine many people take every day for months.

DRAP's risk statement says a spurious or adulterated product can cause the treatment to fail, cause harm, or expose patients to unknown safety risks. A fake capsule may hold the wrong amount of pregabalin, none at all, or something else.

Nouveaux Pharma Limited, of C-21 S.I.T.E. Karachi, holds the marketing authorisation for Sandostatin LAR in Pakistan. It told DRAP that batch 380531 is on sale in the market, but that this batch was made for Turkey and was never supplied to Pakistan by the company.

DRAP calls the batch spurious and falsified. The pack names Novartis Pharmaceutical Manufacturing GmbH in Austria as the maker. Because the batch came in outside the legal supply chain, nobody in Pakistan can vouch for how it was stored or moved.

Sandostatin LAR contains octreotide acetate 20mg. It is a long acting injection, usually given once a month by a doctor or nurse, for acromegaly and some hormone producing tumours. It must be kept cold, so a pack moved outside proper channels may not have been. Warnings on other falsified cancer and specialist injections are collected in falsified cancer medicine alerts.

Five steps to check a Gabica or Sandostatin LAR pack against DRAP alerts 58 and 59: find the batch, compare, keep the pack, call your doctor, report

What to do if you have Gabica 533C27 or Sandostatin LAR 380531

DRAP tells consumers not to use either batch, to contact their doctor if they have had any problem, and to report it. Buy medicines only from licensed pharmacies. Do not stop a medicine on your own without talking to your doctor first.

  1. Find the batch number on your pack. It is printed on the strip, box or vial, often marked "B. No.", "Batch" or "Lot", next to the expiry date.
  2. Compare it with the table above. If it reads 533C27 on Gabica 300mg or 380531 on Sandostatin LAR 20mg, stop using that pack.
  3. Keep the pack and your receipt. Do not throw them away, because an inspector may want to see them.
  4. Call your doctor the same day. Stopping pregabalin suddenly can cause problems such as trouble sleeping, headache and anxiety, so ask for a safe replacement rather than simply stopping.
  5. For Sandostatin LAR, tell the hospital or clinic that gives your injection, and ask them to check the batch before the next dose.
  6. Ask the pharmacy to swap the pack for one from a different batch, bought through the company's legal supply.
  7. Report the pack to DRAP on +92 51 9255969 or gsms@dra.gov.pk, and any side effect through its adverse event reporting system.

How to file a report is explained in how to report a counterfeit medicine to DRAP. If you had a side effect, use how to report a medicine side effect to DRAP.

Pharmacies and hospitals are told to check their stock

DRAP asks healthcare professionals to watch the supply chains of pharmacies, hospitals and clinics that may hold these batches. Provincial drug control field staff have been asked to search the supply chain and seize both batches.

For a pharmacy, the check is simple: look for Gabica 300mg 533C27 and Sandostatin LAR 20mg 380531 on the shelves and in the store. Set aside any found, keep the purchase invoice, and tell the district drug inspector. Any adverse event or quality problem should be reported to the national or provincial pharmacovigilance centre on DRAP's form.

Common questions

Which Gabica batch did DRAP say is fake?

Gabica Capsule 300mg batch 533C27. The Faisalabad drug testing laboratory found it spurious and adulterated, and Getz Pharma has disowned it.

Are all Gabica capsules fake?

No. DRAP's alert names only batch 533C27 of the 300mg strength. Check the batch number on your strip or box.

What is wrong with Sandostatin LAR batch 380531?

It was made for the Turkish market and was never supplied to Pakistan by Nouveaux Pharma, the company that holds the licence here. DRAP calls it spurious and falsified.

Should I stop taking pregabalin?

Stop using a Gabica 533C27 pack, but do not stop pregabalin altogether without your doctor's advice. Ask your doctor or pharmacist for a pack from a different batch.

When did DRAP issue these alerts?

Alert 58 on Gabica is dated 16 November 2026 and was posted at 11:28 am on 17 November. Alert 59 on Sandostatin LAR is dated and was posted on 17 November, at 4:38 pm.

How do I report one of these packs?

Call DRAP on +92 51 9255969 or email gsms@dra.gov.pk, and keep the pack and receipt. You can also tell your district drug inspector.

How we verified this

What we checked and where we read it.

We read both alerts on DRAP's website on 18 November 2026: the alert 58 page on Gabica 300mg and the alert 59 page on Sandostatin LAR, with the PDF notice attached to each. Alert numbers I/S/11-26-58 and I/S/11-26-59, the batch numbers, the maker and licence holder details, the findings and the advice are as the notices state. Posting times are from DRAP's November 2026 archive. The PDF for alert 58 carries the date 16 November 2026; the web page went up on 17 November. The notes on what pregabalin and octreotide are used for are general medical information, not part of the alerts.

About the author

Fajr Riaz, author at Pakistan Era

Public Services and Education Journalist

Fajr Riaz

Fajr Riaz is a journalist and content writer at Pakistan Era, based in Lahore. She covers the questions people meet in everyday life in Pakistan: how a public service works, what a change in the rules means, and where to find a reliable answer.

TopicsDRAPFake MedicineMedicine RecallHealthNews